Literature DB >> 12566696

Transcription at early stages of herpes simplex virus 1 infection and during reactivation.

Ingeborg Rezuchová1, Marcela Kúdelová, Vladmíra Durmanová, Andrea Vojvodová, Ján Kosovský, Július Rajcáni.   

Abstract

OBJECTIVE: The kinetics of immediate early (IE) and early (E) herpes simplex virus 1 (HSV-1) mRNA transcription was followed in explanted trigeminal ganglia from rabbits with established latency.
METHODS: The expression of IE and E mRNAs was first assessed in infected Vero cells by RT-PCR and then in explanted trigeminal ganglia by nested RT-PCR.
RESULTS: In infected Vero cells, IE mRNAs [for infected cell protein (ICP) 0, ICP4 and ICP27] were first detected 1-2 h post-inoculation (p.i.), peaking at 3 h p.i. The transcription of E mRNAs [for thymidine kinase (TK), RR1 and UL9], which were first detected from 3 h p.i., peaked between 5 and 10 h p.i. In explanted ganglia, the ICP0, ICP4 and ICP27 mRNAs were first detected after 4 h in culture. This was followed by the appearance of TK mRNA at 8 h and then by the UL9 mRNA, detected from 12 h post-explantation. A further E mRNA (RR1), as well as the late gC mRNA, were first observed after 24 h in culture. Moreover, ICP4 mRNA could be found in non-cultured ganglia.
CONCLUSIONS: During reactivation of latent HSV-1 in explanted ganglia, the onset of ICP0 and ICP27 transcription at 4 h in culture was followed by TK transcription (at 8 h). Thus, in the rabbit reactivation model, ICP0 gene transcription rather than ICP4 transcription represents the relevant indicator of latency reactivation. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566696     DOI: 10.1159/000068121

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  11 in total

1.  Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 2.  Peculiarities of herpes simplex virus (HSV) transcription: an overview.

Authors:  Július Rajcáni; Vojvodová Andrea; Rezuchová Ingeborg
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

3.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production.

Authors:  Jean M Pesola; Jia Zhu; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.

Authors:  Lihong Li; Zhuoran Li; Erlin Wang; Rui Yang; Yu Xiao; Hongbo Han; Fengchao Lang; Xin Li; Yujie Xia; Feng Gao; Qihan Li; Nigel W Fraser; Jumin Zhou
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

6.  [18F]FHPG positron emission tomography for detection of herpes simplex virus (HSV) in experimental HSV encephalitis.

Authors:  A R Buursma; E F J de Vries; J Garssen; D Kegler; A van Waarde; J Schirm; G A P Hospers; N H Mulder; W Vaalburg; H C Klein
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Authors:  Séverine Maillet; Thierry Naas; Sophie Crepin; Anne-Marie Roque-Afonso; Florence Lafay; Stacey Efstathiou; Marc Labetoulle
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.

Authors:  Kerry J Laing; Amalia S Magaret; Dawn E Mueller; Lin Zhao; Christine Johnston; Stephen C De Rosa; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Clin Immunol       Date:  2010-07-16       Impact factor: 8.542

Review 9.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

10.  Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction.

Authors:  David Shahnazaryan; Rana Khalil; Claire Wynne; Caroline A Jefferies; Joan Ní Gabhann-Dromgoole; Conor C Murphy
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.